Tempus Lens

Agent platform

Agentic platform for oncology drug development that helps teams design better clinical trials, target patient subgroups faster and generate evidence from Tempus's multimodal data.

Find alternatives to Tempus Lens

TypeAgent platform
RoleStandalone tool
AvailabilitySold
Deployment—
Intended forEnterprise, Researcher
SecurityNot recorded
StatusActive
Sold withinPackaging not stated — the vendor’s page was checked and named no parent or plan
PricingEnterprise quote

What it does

Features 6

tempus.com

Sources

Pricing

Official documentation · 25 Aug 2026

The 'Ways to partner' section lists licensing and embedded-team engagements; no list price is published, and tempus.com answers 429 to automated requests so the page was read in a browser.

Description

Press release · 11 Oct 2026

Tempus' launch release (May 2026): Lens helps teams "design better clinical trials, target patient subgroups faster, and generate critical evidence in a fraction of the time"; it does not say Lens simulates trials or generates regulatory evidence.

Sold within

Not found · 30 Sep 2026

Tempus calls Lens "the agentic platform for oncology drug development"; the page offers "CONTACT US", a "LOG IN" link and a feasibility request, noting "All feasibility requests are subject to Tempus’ internal review and approval." No plan, price or self-serve sign-up is stated.

Intended for

Self-reported · 8 Sep 2026

provides scientists/researchers at biopharma companies access to de-identified real-world data; used by 19 of the top 20 largest biopharma companies

Also from Tempus AI

Open Tempus AI in the directory

Something wrong here? Send a correction — quote this product id: tempus-lens.